Pogue-Geile, K. L., Song, N., Jeong, J., Gavin, P. G., Kim, S., Blackmon, N. L., . . . Paik, S. (2015). Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial. J Clin Oncol.
استشهاد بنمط شيكاغوPogue-Geile, Katherine L., et al. "Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial." J Clin Oncol 2015.
MLA استشهادPogue-Geile, Katherine L., et al. "Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial." J Clin Oncol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.